Skip to Content
Merck
CN
  • Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.

Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.

Clinical epigenetics (2023)
Sgro, et al.
PMID37120619